The Technical Analyst
Enovis Corporation [ENOV]
Exchange: NYSE Sector: Industrials Industry: Specialty Industrial Machinery
Enovis Corporation Price, Forecast, Insider, Ratings, Fundamentals & Signals
-3.01% $50.67
America/New_York / 8 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 779.30 mill |
| EPS: | -1.900 |
| P/E: | -26.67 |
| Earnings Date: | Aug 01, 2024 |
| SharesOutstanding: | 54.85 mill |
| Avg Daily Volume: | 0.494 mill |
| RATING 2024-05-08 |
|---|
| C- |
| Strong Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Strong Sell | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -26.67 | sector: PE 26.24 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -1.47x |
| Company: PE -26.67 | industry: PE 18.17 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-7.89 (-115.57%) $-58.56 |
| Date: 2024-05-08 |
| Expected Trading Range (DAY) |
|---|
|
$ 49.17 - 52.17 ( +/- 2.95%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-28 | Lalor Angela S | Buy | 361 | Common stock, par value $0.001 |
| 2024-03-04 | Lang Patricia A | Buy | 9 507 | Common stock, par value $0.001 |
| 2024-03-06 | Lang Patricia A | Sell | 718 | Common stock, par value $0.001 |
| 2024-03-04 | Trerotola Matthew L. | Buy | 64 484 | Common stock, par value $0.001 |
| 2024-03-06 | Trerotola Matthew L. | Sell | 6 157 | Common stock, par value $0.001 |
| INSIDER POWER |
|---|
| 43.58 |
| Last 100 transactions |
| Buy: 375 474 | Sell: 140 532 |
Forecast:
16:00 - $50.67
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $50.67
Forecast 2: 16:00 - $50.67
Forecast 3: 16:00 - $50.67
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $50.67 (-3.01% ) |
| Volume | 0.788 mill |
| Avg. Vol. | 0.494 mill |
| % of Avg. Vol | 159.73 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ENOV
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
ENOV
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Latest Press Releases
2024-05-02 06:00:00 - Press Release
Enovis Announces First Quarter 2024 Results
Wilmington, de, may 02, 2024 (globe newswire) -- enovis™ corporation (nyse: enov), an innovation-driven medical technology growth company, today announced its financial results for the first quarter ended march 29, 2024. the company will host an investor conference call and live webcast to discuss these results today at 8:00 am et.
2024-04-17 07:00:00 - Press Release
Enovis To Host First Quarter 2024 Results Conference Call On May 2nd
Wilmington, de, april 17, 2024 (globe newswire) -- enovis™ corporation (nyse: enov), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2024 financial results on thursday, may 2, 2024 at 8:00 a.m. eastern time and issue an earnings press release earlier that morning. a presentation related to the call will be available on www.enovis.com in the “investors” section.
2024-02-22 06:00:00 - Press Release
Enovis Announces Fourth Quarter And Full Year 2023 Results
Wilmington, de, feb. 22, 2024 (globe newswire) -- —enovis™ corporation (nyse: enov), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and fiscal year ended december 31, 2023. the company will host an investor conference call and live webcast to discuss these results today at 8:30 am et.
2024-02-12 11:30:00 - Press Release
Enovis™ To Highlight Latest Technologies Across The Orthopedic Care Continuum At 2024 Aaos Annual Meeting
Wilmington, de, feb. 12, 2024 (globe newswire) -- enovis™ corporation (nyse: enov), an innovation-driven, medical technology company, will showcase its latest technologies across the orthopedic care continuum at the american academy of orthopedic surgeons annual meeting 2024. in addition, the company will present itself as a newly integrated company following the acquisition of orthopedic leader limacorporate s.p.a (“lima”).
2024-02-07 16:15:00 - Press Release
Enovis To Present At The Canaccord Genuity Musculoskeletal Conference On Monday, February 12, 2024
Wilmington, de, feb. 07, 2024 (globe newswire) -- enovis™ corporation (nyse: enov), an innovation-driven, medical technology growth company, today announced that brady shirley, president and coo, ben berry, cfo, and louis vogt, group president recon will present at the canaccord genuity musculoskeletal conference. the presentation is scheduled to begin at 5:30pm p.m. et (2:30 p.m. pt) on monday, february 12, 2024.
Latest News
2024-05-06 10:36:07 - Zacks Investment Research
Down -15.45% in 4 Weeks, Here's Why You Should You Buy the Dip in Enovis (ENOV)
Enovis (ENOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
2024-05-02 08:11:08 - Zacks Investment Research
Enovis (ENOV) Q1 Earnings Match Estimates
Enovis (ENOV) came out with quarterly earnings of $0.50 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.44 per share a year ago.
2024-04-17 07:00:00 - GlobeNewsWire
Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
Wilmington, DE, April 17, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2024 financial results on Thursday, May 2, 2024 at 8:00 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the “Investors” section.
2024-02-07 16:15:00 - GlobeNewsWire
Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
Wilmington, DE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that Brady Shirley, President and COO, Ben Berry, CFO, and Louis Vogt, Group President Recon will present at the Canaccord Genuity Musculoskeletal Conference. The presentation is scheduled to begin at 5:30pm p.m. ET (2:30 p.m. PT) on Monday, February 12, 2024.
2024-01-26 06:00:00 - GlobeNewsWire
Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
Wilmington, DE, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2023 financial results on Thursday, February 22, 2024 at 8:30AM ET and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the “Investors” section.
2024-01-04 12:02:12 - Zacks Investment Research
Enovis (ENOV) to Strengthen Portfolio Via Its Latest Buyout
Enovis' (ENOV) latest buyout is expected to expand its international scale with a complementary global customer base and product mix and improve efficiency with innovative manufacturing facilities.
2023-11-13 11:17:56 - Zacks Investment Research
Can Enovis (ENOV) Climb 43.82% to Reach the Level Wall Street Analysts Expect?
The mean of analysts' price targets for Enovis (ENOV) points to a 43.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
2023-11-07 08:16:12 - Zacks Investment Research
Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates
Enovis (ENOV) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.59 per share a year ago.
2023-10-31 11:17:54 - Zacks Investment Research
Enovis (ENOV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Enovis (ENOV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2023-10-25 13:32:12 - Zacks Investment Research
Will Enovis (ENOV) Beat Estimates Again in Its Next Earnings Report?
Enovis (ENOV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.